Results 11 to 20 of about 2,187 (160)
Highlights Similar antibody response to COVID‐19 inactivated vaccine between healthy controls (HCs) and patients with type 2 diabetes mellitus (T2DM) after a booster shot vaccine within 6 months. Patients with T2DM have reduced antibody response after receiving the third dose of the COVID‐19 vaccine for more than 6 months. Both HCs and T2DM showed poor
Haolong Li +6 more
wiley +1 more source
Highlights Metformin was associated with statistically significantly lower overall mortality for inpatients and outpatients. Dipeptidyl peptidase‐4 inhibitor use was associated with statistically significant higher hospitalization risk and higher risk of intensive care unit (ICU) admissions and/or mechanical ventilation.
Mahmoud Nassar +4 more
wiley +1 more source
Highlights Cardiovascular risk factors worsened during COVID‐19 in young people with type 1 diabetes. Blood pressure and atherogenic lipid levels were higher in 2020/2021 than expected. No further boost in 2020 and 2021 of the preexisting increase in body mass index‐SD score.
Alexander J. Eckert +11 more
wiley +1 more source
Highlights Diabetic ketoacidosis rate and HbA1c were not elevated in pediatric patients with type 1 diabetes mellitus (T1DM) and severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection. Pediatric patients with known T1DM did not show an elevated COVID‐19 manifestation index; only pediatric patients with coincident SARS‐CoV‐2 infection ...
Bastian Raphael Büttner +9 more
wiley +1 more source
Assessing the effectiveness of public health interventions for Covid‐19 in Greece and Cyprus
Abstract In this article, we statistically examine the effectiveness of non‐pharmaceutical interventions (NPIs) implemented by the national governments of Greece and Cyprus during 2020 to (a) limit the spread of the SARS‐CoV‐2 virus, and (b) mitigate the economic fallout brought about by the Covid‐19 pandemic.
Nikolaos Zahariadis +5 more
wiley +1 more source
Governing with health code: Standardising China's data network systems during COVID‐19
Abstract Noting the infrastructural turn in platform studies, the article conceives China's health code system, Jian Kang Ma (JKM), deployed to manage the COVID‐19 crisis as a new social infrastructure that manifests the symbolic and material power of the Party State.
Yu Sun, Wilfred Yang Wang
wiley +1 more source
Course of Revision of the Diagnosis and Treatment Protocol for COVID-19 and the Forensic Contribution [PDF]
From January 15 to March 3, 2020, seven editions of the guidelines for the diagnosis and treatment of COVID-19 have been issued successively by the National Health Commission of the People’s Republic of China, and the guidelines’name was changed from ...
ZHANG Lu, KONG Ling-jie, ZHANG Jie, et al.
core +1 more source
We trace the crafting of expert narratives during the initial months of the COVID‐19 pandemic in Mainland China, Hong Kong, and the United States. By expert narratives, we refer to how experts drew different lessons from past disease experiences to guide policymakers and the public amidst uncertainty. These expert narratives were mobilized in different
Larry Au, Zheng Fu, Chuncheng Liu
wiley +1 more source
The COVID-19 infection belongs to the category of "blight" in Traditional Chinese Medicine. The course of illness is generally about 7 days, and the recovery period is crucial for COVID-19 patients.
ZHOU Jie (周洁) +7 more
doaj +1 more source
Highlights There has been an increase in new cases of youth onset type 2 diabetes during the pandemic. Non‐Hispanic Black youth have been most affected the increase in youth onset type 2 diabetes during the pandemic. No significant correlation was identified with clinical or biochemical COVID‐19 infection in those tested.
Sean DeLacey +5 more
wiley +1 more source

